P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy

Title
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
Authors
Keywords
Palbociclib, p53, ATM, Radiosensitivity, CDK4/6
Journal
CANCER LETTERS
Volume 451, Issue -, Pages 23-33
Publisher
Elsevier BV
Online
2019-03-11
DOI
10.1016/j.canlet.2019.02.049

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now